The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France
Study Identifier
P15-405
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study seeks to determine the effectiveness of the interferon-free ABBVIE REGIMEN ± ribavirin (RBV) in participants with chronic hepatitis C (CHC) virus in clinical practices across France.
Study Locations
Location
Status
Location
Hopital Saint Joseph /ID# 144927
Marseille, Bouches-du-Rhone, France, 13285
Status
Not applicable
Location
Hopital Saint Joseph /ID# 145560
Marseille, Bouches-du-Rhone, France, 13285
Status
Not applicable
Location
Hopital Saint Joseph /ID# 145571
Marseille, Bouches-du-Rhone, France, 13285
Status
Not applicable
Location
CHR Orleans - Hopital de la Source /ID# 147250
Orléans, Centre-Val De Loire, France, 45067
Status
Not applicable
Location
CHU de Besancon - Jean Minjoz /ID# 145884
Besançon, Doubs, France, 25000
Status
Not applicable
Location
CHU Dupuytren /ID# 144920
Limoges, Franche-Comte, France, 87042
Status
Not applicable
Showing {first} - {last} of {total} Results